Giant rat penis redux: AI-generated diagram, errors lead to retraction

In an episode reminiscent of the AI-generated graphic of a rat with a giant penis, another paper with an anatomically incorrect image has been retracted after it attracted attention on social media. The authors admit using ChatGPT to make the diagram. 

According to the retraction notice published July 12, the article, by researchers at Guangdong Provincial Hydroelectric Hospital in Guangzhou, China, was retracted after “concerns were raised over the integrity of the data and an inaccurate figure.” 

The paper, published in Lippincott’s Medicine, purported to describe a randomized controlled trial that found alkaline water could reduce pain and alleviate symptoms of chronic gouty arthritis.

Continue reading Giant rat penis redux: AI-generated diagram, errors lead to retraction

‘Mistakes were made’: Paper by department chair earns expression of concern as more questioned

Kelly McMasters

A 14-year-old paper has earned an expression of concern after an anonymous whistleblower found evidence of image duplication in the work. 

The authors have had images from several more papers flagged on PubPeer. The corresponding author, Kelly McMasters, is chair of the Hiram C. Polk, Jr., MD Department of Surgery at the University of Louisville School of Medicine in Kentucky. 

The 2010 paper, “Adenovirus-mediated expression of truncated E2F-1 suppresses tumor growth in vitro and in vivo,” appeared in Cancer. It has been cited 12 times, according to Clarivate’s Web of Science. 

Continue reading ‘Mistakes were made’: Paper by department chair earns expression of concern as more questioned

Supplement maker sues critic for defamation, spurring removal of accepted abstract

A Frontiers journal has taken down the abstract of a “provisionally accepted” article about harms from an herbal supplement after the company that sells the products sued the first author for defamation. 

Cyriac Abby Philips

The author of the paper, Cyriac Abby Philips, a hepatologist at Rajagiri Hospital in Kerala, India, has over 266,000 followers on his X account “TheLiverDoc.” In 2020, another of Philips’ papers about harm from supplements was retracted and removed after the large supplement company Herbalife, whose products the paper impugned, put legal pressure on Elsevier. 

Himalaya Wellness, an herbal supplement company which says its products are based on Ayurvedic practices, last year sued Philips for defamation based on his posts on X about the company’s products. 

Continue reading Supplement maker sues critic for defamation, spurring removal of accepted abstract

Exclusive: Kavli prize winner threatens to sue critic for defamation

Chad Mirkin

One of the winners of the 2024 Kavli Prize in nanoscience has threatened to sue a longtime critic, Retraction Watch has learned. 

In a cease and desist letter, a lawyer representing Chad Mirkin, a chemist and director of the International Institute for Nanotechnology at Northwestern University in Chicago, accused Raphaël Lévy, a professor of physics at the Université Paris Sorbonne Nord, of making “patently false and defamatory” statements about Mirkin’s research.

The demand primarily concerns a letter to the editor Lévy submitted in April to Proceedings of the National Academy of Sciences regarding an article Mirkin co-authored, “Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy,” which appeared in the journal in February. 

Continue reading Exclusive: Kavli prize winner threatens to sue critic for defamation

Journal retracts letter to the editor about predatory journals for ‘legal concerns’

A journal has retracted a letter to the editor and removed the online version from its website “because legal concerns were raised to the Publisher,” according to the notice. The retracted letter had referred to multiple journals as “predatory.” 

The retracted letter, “A threat to scientific integrity,” appeared in the British Dental Journal in August 2023. The author, Niall McGuinness, director of the MClinDent / DClinDent programme in orthodontics at the Edinburgh Dental Institute, criticized a May 2023 opinion article, “What does the Dentists Act say about orthodontic treatment choice?” for the articles it cited.

In particular, McGuinness called out citations to publications in journals “of questionable probity in regard to publication ethics – ‘predatory’ journals as defined by Jeffrey Beall, of the University of Colorado,” according to an archived version seen by Retraction Watch. He listed four journals cited in the article, including one from the publisher Frontiers and another from MDPI, which appeared on Beall’s list. 

Continue reading Journal retracts letter to the editor about predatory journals for ‘legal concerns’

‘Rare’ criminal charges for data manipulation in Cassava case send a ‘powerful message’: lawyers

Hoau-yan Wang

The recent criminal indictment of a medical school professor and former scientific advisor to Cassava Sciences on fraud charges for manipulating images in scientific papers and applications for federal funding is a “rare” outcome for such alleged actions that “sends a very, very powerful message.” 

That’s according to lawyers who have worked on research misconduct cases. 

While many investigations by the U.S. Office of Research Integrity and other government watchdogs find scientists manipulated data in grant applications to the National Institutes of Health and National Science Foundation, few are charged with “major fraud against the United States,” as was Hoau-yan Wang

Continue reading ‘Rare’ criminal charges for data manipulation in Cassava case send a ‘powerful message’: lawyers

University president faces allegations of duplication, institution says no misconduct

Masahiro Yoshimoto

The president of the Kyoto Institute of Technology (KIT) has corrected two of his papers and is set to correct another amid allegations of duplication – sometimes inelegantly referred to as “self-plagiarism” – despite a university committee clearing him of misconduct. 

Employees at the university have accused president Masahiro Yoshimoto of duplication between 11 sets of his published papers – implicating 34 papers in total. 

The employees submitted the allegations to the institution last October, backing their claims with an analysis by plagiarism detection software iThenticate. Two of these employees spoke to Retraction Watch on condition of anonymity, fearing a loss of support from their colleagues if they spoke publicly. Their concerns triggered an investigation at KIT, which cleared Yoshimoto of misconduct in January. However, the whistleblowers still believe the papers should be retracted. 

Continue reading University president faces allegations of duplication, institution says no misconduct

Elsevier withdraws plagiarized paper after original author calls journal out on LinkedIn

Sasan Sadrizadeh

In late May, one of Sasan Sadrizadeh’s doctoral students stumbled upon a paper with data directly plagiarized from his previous work. 

Sadrizadeh, a researcher at KTH Royal Institute of Technology in Stockholm, was the last author on “Supply-demand side management of a building energy system driven by solar and biomass in Stockholm: A smart integration with minimal cost and emission,” published in September 2023 in Energy Conversion and Management.

The paper with matching data, “Optimizing smart building energy systems for sustainable living: A realistic approach to enhance renewable energy consumfaption [sic] and reduce emissions in residential buildings,” appeared online as an “article in press” in Elsevier’s Energy and Buildings in May. 

Continue reading Elsevier withdraws plagiarized paper after original author calls journal out on LinkedIn

Seventeen journals lose impact factors for suspected citation manipulation

Clarivate, the company that calculates Journal Impact Factors based on citations to articles, didn’t publish the metric for 17 journals this year due to suspected citation manipulation. That’s a substantial increase from last year, when only four were excluded. 

The increase is, in part, case of rising tides lifting (sinking?) all boats: In its 2024 Journal Citation Reports, Clarivate included an additional 7,200 journals from the Emerging Sources Citation Index (ESCI) and the the Arts and Humanities Citation Index (AHCI), a spokesperson for the company said, resulting in a larger number of impact factor suppressions than in past years. 

Clarivate suppressed nearly twice as many journals in 2020, when it penalized 33 for self-citation. The company suppressed 10 in 2021, and three the following year

Continue reading Seventeen journals lose impact factors for suspected citation manipulation

What a database of more than a thousand dismissive literature reviews can tell us

Richard Phelps

I was once required to testify in a court case. My lawyer gave me a few pieces of advice, but he repeated one  several times, which may be why I remember it. “Never say never,” he said. Or, conversely, never say always. Declarations of absolutes present opposing attorneys too wide an opening. They need to identify only a single example to contradict. In trial courts, one cannot get away with making reckless absolutist claims unchallenged.

In academic scholarship, however, it happens all the time. 

Meet the dismissive literature review, in which an author at the beginning of a journal article declares the published research literature on the topic either nonexistent or so poor in quality that all of it is … dismissible. Typically, no evidence supports the claim. You’ve seen the claims yourself (e.g., “little previous research has, …” “few studies have looked at …,” “there is no research on …,” etc.). With one type of dismissive review — a firstness claim — authors boldly declare themselves to be the first in the history of the world to study a particular topic (as in, “this is the first study of …”).

Continue reading What a database of more than a thousand dismissive literature reviews can tell us